The study coordinated by the Centre for Genomic Regulation (CRG) reproduced the same morphological and functional patterns of neuronal connections in a transgenic mouse as seen in people with Down’s syndrome. Regulating the activity of this protein produced very similar neuronal growth to that in a healthy mouse.
